![]()
|
|
||||||||
(Received for publication, November 20, 1996, and in revised form, January 22, 1997)
From the Department of Pathology, Thomas Jefferson University
School of Medicine, Philadelphia, Pennsylvania 19107
Chronic stimulation of WB rat liver epithelial
cells by angiotensin II (Ang II) resulted in the down-regulation of
both type I and type III myo-inositol 1,4,5-trisphosphate
receptors (IP3Rs). Stimulation with vasopressin,
bradykinin, epidermal growth factor, or
12-O-tetradecanoylphorbol-13-acetate was without effect.
Ang II-induced down-regulation of IP3Rs could be detected
within 2 h and resulted in an inhibition of
IP3-induced Ca2+ release from permeabilized
cells. IP3R down-regulation was reversible, and both homo-
and heterooligomers of IP3Rs were equally susceptible to
Ang II-induced degradation. Chloroquine and NH4Cl increased the basal levels of IP3Rs by 2-fold, suggesting that the
basal turnover of IP3Rs occurs via a lysosomal pathway.
However, Ang II-induced degradation of IP3R was not
affected by these inhibitors, suggesting that stimulated degradation of
IP3Rs occurs via a non-lysosomal pathway. The cysteine
protease and proteasomal inhibitor
N-acetyl-Leu-Leu-norleucinal completely prevented Ang
II-mediated down-regulation of IP3Rs, whereas the
structural analog N-acetyl-Leu-Leu-methioninal was without
effect. Lactacystin, a highly specific proteasome inhibitor, also
blocked Ang II-mediated IP3R degradation. Stimulation with Ang II increased the amount of IP3R immunoprecipitated by
anti-ubiquitin antibodies. We conclude that Ang II-stimulated
IP3R degradation involves enhanced ubiquitination of the
protein and degradation by the proteasome pathway.
Volume 272, Number 19,
Issue of May 9, 1997
pp. 12454-12461
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
EVIDENCE FOR INVOLVEMENT OF THE PROTEASOME PATHWAY
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. M. P. Pearce, Y. Wang, G. G. Kelley, and R. J. H. Wojcikiewicz SPFH2 Mediates the Endoplasmic Reticulum-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors and Other Substrates in Mammalian Cells J. Biol. Chem., July 13, 2007; 282(28): 20104 - 20115. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Li, M. Mogi, K. Tsukuda, H. Tomochika, J. Iwanami, L.-J. Min, C. Nahmias, M. Iwai, and M. Horiuchi Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1 Mol. Endocrinol., February 1, 2007; 21(2): 499 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Bhanumathy, S. K. Nakao, and S. K. Joseph Mechanism of Proteasomal Degradation of Inositol Trisphosphate Receptors in CHO-K1 Cells J. Biol. Chem., February 10, 2006; 281(6): 3722 - 3730. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Kelley, K. A. Kaproth-Joslin, S. E. Reks, A. V. Smrcka, and R. J. H. Wojcikiewicz G-protein-coupled Receptor Agonists Activate Endogenous Phospholipase C{epsilon} and Phospholipase Cbeta3 in a Temporally Distinct Manner J. Biol. Chem., February 3, 2006; 281(5): 2639 - 2648. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Alzayady, M. M. Panning, G. G. Kelley, and R. J. H. Wojcikiewicz Involvement of the p97-Ufd1-Npl4 Complex in the Regulated Endoplasmic Reticulum-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors J. Biol. Chem., October 14, 2005; 280(41): 34530 - 34537. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Williams, M.-L. Liu, Y. Zhu, X. Xu, W. R. Davidson, P. McCue, and K. Sharma Loss of Heparan N-Sulfotransferase in Diabetic Liver: Role of Angiotensin II Diabetes, April 1, 2005; 54(4): 1116 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Chade, J. Herrmann, X. Zhu, J. D. Krier, A. Lerman, and L. O. Lerman Effects of Proteasome Inhibition on the Kidney in Experimental Hypercholesterolemia J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1005 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Auger-Messier, G. Arguin, B. Chaloux, R. Leduc, E. Escher, and G. Guillemette Down-Regulation of Inositol 1,4,5-Trisphosphate Receptor in Cells Stably Expressing the Constitutively Active Angiotensin II N111G-AT1 Receptor Mol. Endocrinol., December 1, 2004; 18(12): 2967 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Webster, S. Tiwari, A. M. Weissman, and R. J. H. Wojcikiewicz Inositol 1,4,5-Trisphosphate Receptor Ubiquitination Is Mediated by Mammalian Ubc7, a Component of the Endoplasmic Reticulum-associated Degradation Pathway, and Is Inhibited by Chelation of Intracellular Zn2+ J. Biol. Chem., October 3, 2003; 278(40): 38238 - 38246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurokawa and R. A. Fissore ICSI-generated mouse zygotes exhibit altered calcium oscillations, inositol 1,4,5-trisphosphate receptor-1 down-regulation, and embryo development Mol. Hum. Reprod., September 1, 2003; 9(9): 523 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ando, A. Mizutani, T. Matsu-ura, and K. Mikoshiba IRBIT, a Novel Inositol 1,4,5-Trisphosphate (IP3) Receptor-binding Protein, Is Released from the IP3 Receptor upon IP3 Binding to the Receptor J. Biol. Chem., March 14, 2003; 278(12): 10602 - 10612. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. H. Wojcikiewicz, Q. Xu, J. M. Webster, K. Alzayady, and C. Gao Ubiquitination and Proteasomal Degradation of Endogenous and Exogenous Inositol 1,4,5-Trisphosphate Receptors in alpha T3-1 Anterior Pituitary Cells J. Biol. Chem., January 3, 2003; 278(2): 940 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Lenz, H. P. Reusch, N. Albrecht, G. Schultz, and M. Schaefer Ca2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells J. Cell Biol., October 28, 2002; 159(2): 291 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Junoy, H. Maccario, J.-L. Mas, A. Enjalbert, and S. V. Drouva Proteasome Implication in Phorbol Ester- and GnRH-Induced Selective Down-Regulation of PKC ({alpha}, {epsilon}, {zeta}) in {alpha}T3-1 and L{beta}T2 Gonadotrope Cell Lines Endocrinology, April 1, 2002; 143(4): 1386 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hines, J. N. Heerding, S. J. Fluharty, and D. K. Yee Identification of Angiotensin II Type 2 (AT2) Receptor Domains Mediating High-Affinity CGP 42112A Binding and Receptor Activation J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 665 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lee, W. Gai, and S. G. Laychock Proteasomal Activation Mediates Down-Regulation of Inositol 1,4,5-Trisphosphate Receptor and Calcium Mobilization in Rat Pancreatic Islets Endocrinology, May 1, 2001; 142(5): 1744 - 1751. [Abstract] [Full Text] |
||||
![]() |
A. Gonzalez Iglesias, C. Suarez, C. Feierstein, G. Diaz-Torga, and D. Becu-Villalobos Desensitization of angiotensin II: effect on [Ca2+]i, inositol triphosphate, and prolactin in pituitary cells Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E462 - E470. [Abstract] [Full Text] [PDF] |
||||
![]() |
Yi Xu, V. Menon, and B. I Jugdutt Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-{varepsilon} in acutely reperfused myocardial infarction in the dog: Effect of UP269-6 and losartan on AT1- and AT2-receptor expression and IP3 receptor and PKC{varepsilon} proteins Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 184 - 195. [Abstract] [PDF] |
||||
![]() |
K. Sharma, T. A. Mc Gowan, L. Wang, M. Madesh, V. Kaspar, G. Szalai, A. P. Thomas, and G. Hajnoczky Inhibition of type I and III IP3Rs by TGF-beta is associated with impaired calcium release in mesangial cells Am J Physiol Renal Physiol, June 1, 2000; 278(6): F1022 - F1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. He, P. Damiani, T. Ducibella, M. Takahashi, K. Tanzawa, J. B. Parys, and R. A. Fissore Isoforms of the Inositol 1,4,5-Trisphosphate Receptor Are Expressed in Bovine Oocytes and Ovaries: The Type-1 Isoform Is Down-Regulated by Fertilizationand by Injection of Adenophostin A Biol Reprod, October 1, 1999; 61(4): 935 - 943. [Abstract] [Full Text] |
||||
![]() |
C.-C. Zhu, T. Furuichi, K. Mikoshiba, and R. J. H. Wojcikiewicz Inositol 1,4,5-Trisphosphate Receptor Down-regulation Is Activated Directly by Inositol 1,4,5-Trisphosphate Binding. STUDIES WITH BINDING-DEFECTIVE MUTANT RECEPTORS J. Biol. Chem., February 5, 1999; 274(6): 3476 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sharma, L. Wang, Y. Zhu, A. DeGuzman, G.-Y. Cao, R. B. Lynn, and S. K. Joseph Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice Am J Physiol Renal Physiol, January 1, 1999; 276(1): F54 - F61. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Wilson, J. R. Pfeiffer, A. J. Smith, J. M. Oliver, J. A. Oberdorf, and R. J.H. Wojcikiewicz Calcium-dependent Clustering of Inositol 1,4,5-Trisphosphate Receptors Mol. Biol. Cell, June 1, 1998; 9(6): 1465 - 1478. [Abstract] [Full Text] |
||||
![]() |
R. L. Mellgren Specificities of Cell Permeant Peptidyl Inhibitors for the Proteinase Activities of µ-Calpain and the 20 S Proteasome J. Biol. Chem., November 21, 1997; 272(47): 29899 - 29903. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |